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SUMMARY
Background and objectives: Human Bocavirus (HBoV) has been described since 2005 as an etiological agent of respiratory 
virus infections. From 2001 to 2008 we investigated the etiology of HBoV among adults and children in different groups at risk of 
presenting complications arising from acute respiratory infection, the investigation was carried out in a tertiary hospital health care 
system in Brazil. Methods: HBoV DNA was assayed in 598 respiratory samples from community and hospitalized patients by PCR. 
Results: Of the 598 tested samples, 2.44% (8/328) of children, including five children with heart disease, and 0.4% (1/270) of adult 
bone-marrow-transplant were HBoV positive. Conclusions: These data suggested lower HBoV frequency among different at-risk 
patients and highlights the need to better understand the real role of HBoV among acute respiratory symptomatic patients. 
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INTRODUCTION
Human bocavirus (HBoV) infections have been reported in children 
with upper and subsequent lower respiratory tract infections, with rates 
ranging from 1.4% to 19%2. There is a lack of information about the role of 
this pathogen in the etiology of acute respiratory infections (ARI) among 
patients in different risk groups. Studies among adult lung-transplant 
recipients or other immunocompromised patients detected a rate of 
3.1% HBoV infection9. SCHENK et al. (2007)19 reported disseminated 
HBoV infection in a pediatric patient weeks after hematopoietic stem-cell 
transplantation. The aim of the study was to investigate the etiology of 
HBoV among adults and children in different groups at risk of presenting 
acute respiratory infections from 2001 to 2008. 
PATIENTS AND METHODS
Population: Five hundred and ninety-eight samples collected from 
five different risk groups between 2001 and 2008 were assayed for 
DNA HBoV. Patients with a clinical diagnosis of Acute Respiratory 
Infection (ARI), up to seven days after onset of symptoms, of possible 
viral etiology (as determined by a physician), were considered eligible. 
Subjects were enrolled on a daily basis whenever a physician contacted 
the study team. The included patients were interviewed by the research 
staff, and information about demographic data, history of symptoms, 
clinical presentation, comorbidities, and influenza vaccination status 
were collected. Overall, 328 children (mean, median and range: 2.4 years 
old, one year old, 22 days-11 years old) and 270 adults (mean, median 
and range: 40.9, 42, 15-83 years old), with a median age of 21 years 
(ranging from 22 days to 83 years), were evaluated by a physician who 
collected samples (nasal wash for adults and nasopharyngeal aspirate 
for children) and sent them to the Virology Laboratory of the Sao Paulo 
Federal University. This study was approved by the Ethics Committee of 
Sao Paulo Federal University, and written consent was obtained from all 
patients or from those responsible for the individual patient. 
Yearly Recruitment centers: From 2001 to 2003, 83 outpatient 
healthcare workers (HCW), 44 adult patients from the emergency 
room (ER) and 31 renal-transplant outpatients (RT) were evaluated; 64 
ambulatory pediatric patients with congenital heart disease (CHD) were 
sampled in 2005, and in 2008 we received samples from 161 children 
from a day-care center, 103 CHD children, and 112 hospitalized adult 
bone-marrow-transplant patients (BMT). All demographic and clinical 
data were recorded. 
All 598 samples were prospectively investigated for antigen detection 
of influenza A and B, parainfluenza (types 1-3), adenovirus, and RSV 
by Direct Fluorescence Assay (DFA). Negative samples of the adults 
recruited first (2001-2003) were also tested for human metapneumovirus 
(hMPV), human rhinovirus (HRV), enterovirus (HEV), and coronavirus 
(HCoV) 229E and OC43, as previously described3, and those without 
another virus were tested for HBoV. 
DNA HBoV detection and nucleotide sequencing: Viral DNA 
was extracted using the QIAmp Blood DNA Mini kit (Qiagen, USA) 
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according to the manufacturer´s instructions. HBoV DNA detection 
was performed by PCR for the NP-1 gene amplification as described 
elsewhere, with minor modifications12. As a positive control, we used a 
HBoV PCR product cloned into the plasmid pCRII-TOPOXL (Invitrogen, 
USA). The assay was standardized for detection at 40 copies of plasmid 
per reaction. All HBoV-positive samples were confirmed by sequencing 
with the same PCR primers. Sequencing reactions were performed using 
the Big Dye Terminator kit (Applied Biosystems, USA) and the ABI 
Prism 3130XL DNA sequencer. The sequences were aligned using the 
ClustalX program12. Phylogenetic relationships for the NP-1 sequences 
were assessed using maximum likelihood (ML) methods. Trees were 
replicated 100 times to provide bootstrap support for clades. The analysis 
was performed using Topali v2.5 software16. Eleven published HBoV 
sequences within the NP-1 region were obtained from the GenBank 
database (NCBI). 
RESULTS
We obtained nine (1.5%) HBoV-DNA positives from 598 respiratory 
samples. Table 1 shows the study population characteristics and HBoV-
infected patients. Overall, 2.44% of the children (8/328) and 0.40% 
of the adults (1/270) were HBoV-DNA-positive: no positive case was 
found among emergency-room patients. Positive patients (7/9; 77%) 
had samples collected within five days of symptom onset (a median of 
three days). The clinical data presented by HBoV-infected patients are 
shown in Table 2. 
Distribution of positive samples in the period of study was as follows: 
66.7% (6/9) were detected in autumn, 11.1% (1/9) in summer, 11.1% 
(1/9) in winter, and 11.1% (1/9) in spring.
Among the positive cases, 77% (7/9) presented coryza and cough, and 
55% (5/9) presented fever. Among the positive pediatric cases, 25% (2/8) 
presented dyspnea and wheezing, and 12.5% (1/8) presented cyanosis. 
Overall, the patients with HBoV infection presented mild outcomes. 
None of the HBoV-infected patients required hospitalization or other 
supported therapy. Patients 6 and 7 (Table 2) were in close contact in 
the same classroom and had a one-day interval between symptom onset. 
All positive samples were sequenced, and six were assessed through 
phylogenetic analysis. Five out of six samples clustered with HBoV 1. 
One sample did not cluster with any of the reference sequences, probably 
due to a low sequence quality. Four of the obtained sequences were 
deposited in GenBank (accession numbers GQ244405.1, GQ244406.1, 
GQ244407.1, and GQ244408.1).
DISCUSSION
Overall, the detection found in our study (1.5%) was similar to those 
published elsewhere - 1.4% to 19%7. The majority of studies have been 
performed among hospitalized patients and nosocomial infection was 
also reported6.
HBoV infection occurred differentially among distinct risk groups 
of patients with acute respiratory symptoms; infections occurred more 
frequently among outpatient children than in adults, mainly among 
children with congenital heart disease. However, none of the CHD 
patients had a worse outcome or were hospitalized. One of few studies 
Table 1 
Risk-group patients evaluated for HboV
Risk groupa samples (n)
Median Age 
(years) HBoV + (n) %
Day Care 161 5.0 3 1.8
CHD children 167 3.0 5 2.9
ER adults 44 30 0 0.0
RT adults 31 38.0 0 0.0
HCWs 83 38.5 0 0.0
BMT adults 112 44.8 1 0.9
Total 598 21.0 9 1.5
aoutpatient healthcare workers (HCW), emergency room (ER), renal-transplant 
outpatients (RT), congenital-heart-disease children (CHD), and hospitalized adult 
bone-marrow-transplant patients (BMT).
Table 2
Demographic and clinical data for HBoV-infected patients
N Group Age Sex Timea Symptoms
1 CHD 4 months male 4 fever, coryza, cough, dyspnea
2 CHD 1 year male 1 fever, coryza, cough, cyanosis
3 CHD 1 year female 5 coryza, cough
4 CHD 2 years female 2 fever, coryza
5 CHD 4 years male 2 coryza
6b DC 3 years male 3 fever, coryza, cough, dyspnea, wheezing
7b DC 10 months female 3 coryza, cough, wheezing
8 DC 7 months female 5 fever, coryza, cough
9 BMT 22 years male 2 coryza, cough
Congenital-heart-disease children (CHD), day-care center (DC), and hospitalized bone-marrow-transplant adults (BMT).
aTime since onset of symptoms in days. bChildren in the same classroom. 
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in heart-disease patients reported an 18.8% occurrence of HBoV4, but 
these cases were hospitalized children. 
Previous studies found no HBoV infection among symptomatic 
adults1, and others reported frequencies of less than 1% among those 
and/or the elderly14,15. Although GUIDO et al. (2011) described an HBoV 
frequency of 18.9% among immunocompetent adults10. Other authors 
have suggested that HBoV infection may be a cause of hospitalization in 
the immunocompromised adult population4,14. We found only one adult 
bone-marrow-transplant case of HBoV infection, who presented mild 
disease even though coinfected with metapneumovirus.
In the present study HBoV were found circulating all year round, with 
an increased occurrence in late autumn. GAGLIARDI et al. (2009) in a 
study performed in the same geographical region (Brazilian southwest), 
found a similar autumn seasonality pattern8. Other viruses circulating 
during the same period in Brazil, such as HRSV17 and HRV20, possibly 
lead physicians to misdiagnose some illnesses as HboV, it may also 
account for some coinfections.
Sequences analysis confirmed that a single strain of HBoV circulated 
during the study period and that it was similar to strains described 
worldwide11,13. There was no difference in the strains circulating among 
children and adults, including the two HBoV-infected children in the 
same classroom. 
The study presented was carried out as a hospital-based surveillance 
but the included patients were not hospitalized, except for the BMT 
population. The inclusion of inpatients (BMT) and outpatients (HCWs, 
children from a day-care center and CHD children) may have reduced 
the selection bias.
The inclusion of a control group of asymptomatic patients was not 
accomplished in the present investigation due to ethical questions related 
to healthy children sampling. Indeed, the retrospective design of the study 
would not allow the inclusion of a new patient group.
One of the study’s limitations was that viral loads were not available 
since we tested samples by qualitative PCR and the possible roles of 
these viruses in coinfections were not assessed. PROENÇA-MODENA 
et al. (2011) used a quantitative PCR assay targeting the HBoV mRNA 
and described the probable HBoV pathogenicity in coinfections if higher 
mRNA loads occurred, probably indicating an active replication18. Another 
limitation was the long study period but we assumed that the collection of 
appropriate samples and appropriate storage could minimize possible bias. 
Recently, ALLANDER et al. (2007) discussed a model in which 
primary HBoV infection occurs in early life and is a systemic infection 
associated with respiratory symptoms2. The infection seems to be 
frequently followed by asymptomatic low level virus shedding in the 
respiratory tract. Following this point of view we could speculate that 
this biological dynamic would explain the low frequency of single 
HBoV infection we obtained and the absence of infection among 
immunocompetent adult patients. 
CONCLUSION
In conclusion, our results showed that HBoV infection among risk 
groups was lower, including highly immunosuppressed patients, and this 
highlights the need to better understand the real role of the HBoV among 
acute respiratory symptomatic patients.
RESUMO
Frequência de bocavírus humano em infecções respiratórias entre 
pacientes de risco na cidade de São Paulo, Brasil
Introdução e objetivos: O bocavírus humano (HBoV) tem sido 
descrito desde 2005 como agente etiológico de infecções respiratórias 
virais. O presente estudo tem como objetivo investigar a etiologia da 
infecção respiratória pelo HBoV em pacientes adultos e crianças de 
diferentes grupos de risco para complicação de infecções respiratórias 
agudas desde 2001 até 2008 em um hospital terciário no Brasil. 
Pacientes e Métodos: O HBoV foi investigado, através de reação 
em cadeia da polimerase, em 598 amostras respiratórias coletadas de 
pacientes hospitalizados e não hospitalizados. Resultados: Das 598 
amostras testadas o HBoV foi detectado em 2,44% (8/328) das crianças, 
incluindo cinco crianças portadoras de cardiopatia congênita, e 0,4% 
(1/270) dos adultos em programa de transplante de células tronco 
hematopoiéticas. Conclusão: Os dados do presente estudo sugerem 
baixa freqüência de detecção do HBoV entre pacientes de risco, e 
destaca a necessidade de novos estudos para um melhor entendimento 
do verdadeiro papel desse agente em infecções respiratórias agudas 
em pacientes sintomáticos.
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